Name: Name:5-bromo-3-(propan-2-yl)-1H-indole
Brand: AABLOCKS
SKU: AA01BI7U
Rating: 90 (10 reviews)

Technical Information

Catalog Number: AA01BI7U

Chemical Name: 5-bromo-3-(propan-2-yl)-1H-indole

CAS Number: 439612-51-8

Molecular Formula: C11H12BrN

Molecular Weight: 238.1237

MDL Number: MFCD28670377

SMILES: Brc1ccc2c(c1)c(c[nH]2)C(C)C

Properties

Downstream Synthesis Route

589-21-9

590-86-3

439612-51-8

[1]CurrentPatentAssignee:ALIGOSTHERAPEUTICS-WO2020/227549,2020,A1Locationinpatent:Paragraph00239

[2]CurrentPatentAssignee:BAYERAG-WO2004/60871,2004,A1Locationinpatent:Page/Pagecolumn38

[3]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2012/162129,2012,A1Locationinpatent:Page/Pagecolumn84-85

[4]CurrentPatentAssignee:BAYERAG-US2007/149514,2007,A1

10075-50-0

67-64-1

439612-51-8

[1]CurrentPatentAssignee:BIOCONLIMITED;BRISTOL-MYERSSQUIBBCO-WO2018/5586,2018,A1Locationinpatent:Page/Pagecolumn131

[2]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-WO2018/26620,2018,A1Locationinpatent:Page/Pagecolumn155

[3]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-WO2018/49089,2018,A1Locationinpatent:Page/Pagecolumn85-86

[4]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-WO2019/28302,2019,A1Locationinpatent:Page/Pagecolumn52;53

[5]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-WO2019/28301,2019,A1Locationinpatent:Page/Pagecolumn37

[6]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-WO2019/99336,2019,A1Locationinpatent:Page/Pagecolumn87;151;152

[7]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-WO2019/126242,2019,A1Locationinpatent:Page/Pagecolumn49;50

[8]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-WO2019/118799,2019,A1Locationinpatent:Page/Pagecolumn47;48

[9]Mussari,ChristopherP.;Dodd,DharmpalS.;Sreekantha,RatnaKumar;Pasunoori,Laxman;Wan,Honghe;Posy,ShanaL.;Critton,David;Ruepp,Stefan;Subramanian,Murali;Watson,Andrew;Davies,Paul;Schieven,GaryL.;Salter-Cid,LuisaM.;Srivastava,Ratika;Tagore,DebaratiMazumder;Dudhgaonkar,Shailesh;Poss,MichaelA.;Carter,PercyH.;Dyckman,AlaricJ.[ACSMedicinalChemistryLetters,2020,vol.11,#9,p.1751-1758]

[10]Carter,PercyH.;Critton,David;Dodd,DharmpalS.;Dudhgaonkar,Shailesh;Dyckman,AlaricJ.;Hegde,Subramanya;Macor,JohnE.;Mussari,ChristopherP.;Pasunoori,Laxman;Poss,MichaelA.;Posy,ShanaL.;Ruepp,Stefan;Salter-Cid,LuisaM.;Sarodaya,Sanket;Schieven,GaryL.;Sreekantha,RatnaKumar;Subramanian,Murali;Tagore,DebaratiMazumder[ACSMedicinalChemistryLetters,2022]

[11]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-WO2019/126113,2019,A1Locationinpatent:Page/Pagecolumn53;54

[12]Beutner,GregoryL.;Simmons,EricM.;Ayers,Sloan;Bemis,ChristopherY.;Goldfogel,MatthewJ.;Joe,CandiceL.;Marshall,Jonathan;Wisniewski,StevenR.[JournalofOrganicChemistry,2021,vol.86,#15,p.10380-10396]

[13]CurrentPatentAssignee:IDORSIAPHARMACEUTICALSLTD-WO2015/186056,2015,A1Locationinpatent:Page/Pagecolumn111

4334-87-6

439612-51-8

ethyl3-(3-isopropyl-1H-indol-5-yl)benzoate

[1]Patent:WO2019/126253,2019,A1.Locationinpatent:Page/Pagecolumn67-68

439612-51-8 | 5-bromo-3-(propan-2-yl)-1H-indole